Aytu Biopharma, Inc.
AYTU
$1.90
-$0.07-3.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.64M | -5.24M | -6.25M | -15.84M | -13.68M |
| Total Depreciation and Amortization | 5.64M | 5.86M | 6.31M | 6.73M | 7.28M |
| Total Amortization of Deferred Charges | 216.00K | 350.00K | 476.00K | 597.00K | 1.02M |
| Total Other Non-Cash Items | -3.89M | -3.04M | 2.14M | 13.86M | 16.98M |
| Change in Net Operating Assets | -9.14M | 2.75M | -5.05M | -6.73M | -2.83M |
| Cash from Operations | -5.53M | 673.00K | -2.37M | -1.39M | 8.77M |
| Capital Expenditure | -211.00K | -142.00K | -136.00K | -- | -- |
| Sale of Property, Plant, and Equipment | 668.00K | 668.00K | 517.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.00K | -79.00K | -253.00K | -329.00K | -450.00K |
| Cash from Investing | 423.00K | 447.00K | 128.00K | -329.00K | -450.00K |
| Total Debt Issued | 21.45M | 15.45M | 15.71M | 13.83M | -6.57M |
| Total Debt Repaid | -17.05M | -16.07M | -15.82M | -15.72M | -2.34M |
| Issuance of Common Stock | 3.38M | 3.38M | 3.47M | 3.47M | 2.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.27M | -3.01M | -975.00K | -2.84M | -1.47M |
| Cash from Financing | 3.52M | -251.00K | 2.38M | -1.26M | -7.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.59M | 869.00K | 144.00K | -2.98M | 581.00K |